Document is current

Article History

Received: 8 February 2024

Accepted: 15 July 2024

First Online: 2 September 2024

Declarations

:

: This study was conducted in accordance with the amended Declaration of Helsinki. The NIH-sponsored multicenter Genetic Epidemiology of COPD (COPDGene) study was approved and reviewed by the institutional review board (ClinicalTrials.gov Identifier: NCT00608764) including: National Jewish IRB, Partners Human Research Committee, Institutional Review Board for Baylor College of Medicine and Affiliated Hospitals, Institutional Review Board for Baylor College of Medicine and Affiliated Hospitals, Columbia University Medical Center IRB, The Duke University Health System Institutional Review Board for Clinical Investigations (DUHS IRB), Johns Hopkins Medicine Institutional Review Boards (JHM IRB), The John F. Wolf, MD Human Subjects Committee of Harbor UCLA Medical Center, Morehouse School of Medicine Institutional Review Board, Temple University Office for Human Subjects Protections Institutional Review Board, The University of Alabama at Birmingham Institutional Review Board for Human Use, University of California, San Diego Human Research Protections Program, The University of Iowa Human Subjects Office, VA Ann Arbor Healthcare System IRB, University of Minnesota Research Subjects’ Protection Programs (RSPP), University of Pittsburgh Institutional Review Board, UT Health Science Center San Antonio Institutional Review Board, Health Partners Research Foundation Institutional Review Board, Medical School Institutional Review Board (IRBMED), Minneapolis VAMC IRB Institutional Review Board/Research Review Committee Saint Vincent Hospital Fallon Clinic Fallon Community Health Plan.All study participants provided written informed consent.

: Not applicable

: The authors declare no competing interests.